ELAN — Elanco Animal Health Incorporated Share News
0.000.00%
Last trade - 00:00- $11.76bn
- $15.15bn
- $4.72bn
U.S. STOCKS ON THE MOVE-Bio-Techne, Johnson Controls, Tempus AI
Elanco Animal Health Inc reports results for the quarter ended March 31 - Earnings Summary
Elanco gains on Q1 beat, raised forecast
Brief: Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown
Brief: Elanco Animal Health announces changes to board of directors
Elanco Animal Health Inc reports results for the quarter ended December 31 - Earnings Summary
Leerink starts coverage of animal health firms, sees vet clinic visits improving
Brief: Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain
Press Digest: Wall Street Journal - Nov 13
Elanco Animal Health to pay $15 mln to settle SEC fraud case
Brief: Elanco Strengthens Board Of Directors With Addition Of Stacey Ma
Elanco Animal Health Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Elanco Animal Health Q3 Revenue USD 1,030 Million Vs. IBES Estimate USD 1,034 Million
Brief: Elanco Animal Health Inc Received Approval For Zenrelia In Canada - SEC Filing
US FDA approves Elanco's treatment for parasitic infections in dogs (updated)
US FDA approves Elanco's treatment for parasitic infections in dogs
Brief: Elanco Announces FDA Approval And Launch Of Zenrelia (Ilunocitinib Tablets)
U.S. STOCKS ON THE MOVE-Children's Place, US energy sector, retailers
US FDA approves Elanco's skin disease treatment for dogs (updated)